These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 32281503

  • 1. Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection.
    Thulasi Raman R, Anurekha M, Lakshman V, Balasubramaniam R, Ramya U, Revathi R.
    Leuk Lymphoma; 2020 Aug; 61(8):1974-1980. PubMed ID: 32281503
    [Abstract] [Full Text] [Related]

  • 2. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA, Spasova MI, Murdjeva MA, Stoyanova AA, Mumdziev IN, Kaleva VI, Belcheva MI, Bosheva MN.
    Folia Med (Plovdiv); 2016 Mar 01; 58(1):28-35. PubMed ID: 27383875
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
    Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Panda D, Pradhan SN, Girase K, Narula G, Dhamane C, Malik NR, Banavali S, Patkar NV, Gujral S, Subramanian PG, Tembhare PR.
    Cytometry B Clin Cytom; 2021 Jul 01; 100(4):434-445. PubMed ID: 32896101
    [Abstract] [Full Text] [Related]

  • 4. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM, Verzhbitskaia TIu, Tsaur GA, Shorikov EV, Savel'ev LI, Tsvirenko SV, Fechina LG.
    Klin Lab Diagn; 2010 Aug 01; (8):36-41. PubMed ID: 20886718
    [Abstract] [Full Text] [Related]

  • 5. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
    Tsitsikov E, Harris MH, Silverman LB, Sallan SE, Weinberg OK.
    Int J Lab Hematol; 2018 Jun 01; 40(3):343-351. PubMed ID: 29500862
    [Abstract] [Full Text] [Related]

  • 6. Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry.
    Arumugam JR, Bommannan K, Radhakrishnan V, Sagar TG, Sundersingh S.
    Leuk Lymphoma; 2022 Mar 01; 63(3):644-652. PubMed ID: 34727819
    [Abstract] [Full Text] [Related]

  • 7. Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.
    Baraka A, Sherief LM, Kamal NM, Shorbagy SE.
    Int J Hematol; 2017 Jun 01; 105(6):784-791. PubMed ID: 28324281
    [Abstract] [Full Text] [Related]

  • 8. 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
    Chatterjee G, Dhende P, Raj S, Shetty V, Ghogale S, Deshpande N, Girase K, Patil J, Kalra A, Narula G, Dalvi K, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR.
    Eur J Haematol; 2024 Jan 01; 112(1):122-136. PubMed ID: 37706583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
    Chou SW, Su YH, Lu MY, Chang HH, Yang YL, Lin DT, Lin KH, Coustan-Smith E, Jou ST.
    Pediatr Blood Cancer; 2023 Jan 01; 70(1):e29990. PubMed ID: 36250996
    [Abstract] [Full Text] [Related]

  • 12. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M, Sun XF, Xu ZM, Zhang XY, Li FR, Wang XG, Chen XL, Lin HQ, Wen HG, Sun X, Song TW.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug 01; 13(4):557-62. PubMed ID: 16129033
    [Abstract] [Full Text] [Related]

  • 13. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
    Liu YR, Zhang LP, Chang Y, Cheng YF, Fu JY, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 01; 27(5):302-5. PubMed ID: 16875577
    [Abstract] [Full Text] [Related]

  • 14. Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.
    Gaipa G, Basso G, Maglia O, Leoni V, Faini A, Cazzaniga G, Bugarin C, Veltroni M, Michelotto B, Ratei R, Coliva T, Valsecchi MG, Biondi A, Dworzak MN, I-BFM-ALL-FCM-MRD Study Group.
    Leukemia; 2005 Jan 01; 19(1):49-56. PubMed ID: 15538405
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF.
    Leukemia; 1999 Mar 01; 13(3):419-27. PubMed ID: 10086733
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
    Liu YR, Chang Y, Fu JY, Cheng YF, Zhang LP, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 01; 27(5):335-8. PubMed ID: 16875586
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR, Ghogale S, Ghatwai N, Badrinath Y, Kunder N, Patkar NV, Bibi AR, Chatterjee G, Arora B, Narula G, Banawali S, Deshpande N, Amare P, Gujral S, Subramanian PG.
    Cytometry B Clin Cytom; 2018 Jan 01; 94(1):100-111. PubMed ID: 27718302
    [Abstract] [Full Text] [Related]

  • 19. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 01; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec 01; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.